Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.
Research that followed patients for more than 13 years suggests increases in ECG PR interval, P‐wave duration and PTFV1 are associated with increased AFib risk in this cohort.
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.
Just because it’s efficient doesn’t mean it’s effective. Nowhere is this thought more deserving of reflection than in healthcare AI—especially when it’s applied to clinical decision support.
Neiman researchers recently scoured for factors that might impact screening rates across cancers of the colon/rectum, lung, breast and prostate, using nationwide Medicare data.
CMS explains how IR specialists can submit prior authorization requests to the federal payment program for seniors, including what evidence is required.
The flexible device is attached to the inner wall of the left ventricle during a minimally invasive procedure. It was designed to reduce the size of the left ventricle over time.
Researchers tracked patients for two years, using echocardiography to confirm the devices had completely vanished. Additional studies will still be required.
Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.
Research that followed patients for more than 13 years suggests increases in ECG PR interval, P‐wave duration and PTFV1 are associated with increased AFib risk in this cohort.
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.
